TWST Twist Bioscience Corp

Price (delayed)

$41.21

Market cap

$2.4B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.36

Enterprise value

$2.25B

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights

TWST's revenue is up by 22% YoY and by 6% from the previous quarter

TWST's gross profit is up by 13% since the previous quarter and by 13% year-on-year

TWST's gross margin is down by 7% year-on-year but it is up by 7% since the previous quarter

Twist Bioscience's equity has decreased by 20% YoY and by 5% QoQ

TWST's quick ratio is down by 19% year-on-year and by 8% since the previous quarter

Sector: Healthcare

Industry: Diagnostics & Research

Website: https://www.twistbioscience.com/

Peers: NVCR NVAX

Key stats

What are the main financial stats of TWST

Market

Shares outstanding

58.23M

Market cap

$2.4B

Enterprise value

$2.25B

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

4.25

Price to sales (P/S)

8.58

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

8.09

Earnings

Revenue

$277.49M

EBIT

-$191.27M

EBITDA

-$155.32M

Free cash flow

-$95.52M

Per share

EPS

-$3.36

Free cash flow per share

-$1.65

Book value per share

$9.69

Revenue per share

$4.8

TBVPS

$9.78

Balance sheet

Total assets

$702.85M

Total liabilities

$142.72M

Debt

$89.43M

Equity

$560.13M

Working capital

$304.38M

Liquidity

Debt to equity

0.16

Current ratio

5.51

Quick ratio

4.88

Net debt/EBITDA

0.99

Margins

EBITDA margin

-56%

Gross margin

38.3%

Net margin

-69.2%

Operating margin

-74.5%

Efficiency

Return on assets

-25.4%

Return on equity

-31.6%

Return on invested capital

-52.8%

Return on capital employed

-30.1%

Return on sales

-68.9%

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

TWST stock price

How has the Twist Bioscience stock price performed over time

Intraday

28.74%

1 week

30.66%

1 month

23.61%

1 year

236.13%

YTD

11.8%

QTD

20.11%

Financial performance

How have Twist Bioscience's revenue and profit performed over time

Revenue

$277.49M

Gross profit

$106.26M

Operating income

-$206.76M

Net income

-$192.14M

Gross margin

38.3%

Net margin

-69.2%

Twist Bioscience's net margin has increased by 26% YoY and by 12% from the previous quarter

Twist Bioscience's operating margin has increased by 24% YoY and by 11% QoQ

TWST's revenue is up by 22% YoY and by 6% from the previous quarter

TWST's gross profit is up by 13% since the previous quarter and by 13% year-on-year

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation

P/E

N/A

P/B

4.25

P/S

8.58

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

8.09

TWST's EPS is up by 10% year-on-year and by 7% since the previous quarter

TWST's P/B is 57% above its last 4 quarters average of 2.7 but 18% below its 5-year quarterly average of 5.2

Twist Bioscience's equity has decreased by 20% YoY and by 5% QoQ

TWST's P/S is 60% below its 5-year quarterly average of 21.2 but 38% above its last 4 quarters average of 6.2

TWST's revenue is up by 22% YoY and by 6% from the previous quarter

Efficiency

How efficient is Twist Bioscience business performance

TWST's return on sales is up by 26% year-on-year and by 12% since the previous quarter

The return on equity has declined by 14% year-on-year

The ROA has decreased by 10% YoY

Twist Bioscience's ROIC has decreased by 10% YoY

Dividends

What is TWST's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time

The current ratio has contracted by 19% YoY and by 8% from the previous quarter

TWST's quick ratio is down by 19% year-on-year and by 8% since the previous quarter

Twist Bioscience's debt is 84% less than its equity

Twist Bioscience's debt to equity has increased by 23% YoY

Twist Bioscience's equity has decreased by 20% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.